IMRN

IMMURON LTD

IMRN·45254U101·US·ADR·Healthcare - Biotechnology

IMRN (IMMURON LTD) is held by 6 institutional investors as of Q1 2026. Largest holders: MORGAN STANLEY ($23,689), XTX Topco Ltd ($13,468), CITADEL ADVISORS LLC ($10,695). Net institutional sentiment: Mixed.

6
Holders
Avg rating(1 Elite)
$57,298
Total Value
33% (9)
Fund Consensus
3 buying - 6 selling

No verdict yet — fewer than 2 funds hold IMRN.

13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Decreased
30,574(-46.7%)$23,6890.0%+9.69%
0
Increased
17,383(+23.1%)$13,4680.0%-27.57%
22
Decreased
13,804(-69.8%)$10,6950.0%-1.59%
0
Increased
7,367(+63.9%)$5,7080.0%-32.44%
15
Decreased
4,600(-2.1%)$3,5640.0%+14.41%
0
New
225$1740.0%+66.22%
17
Exited
0(-100.0%)$9,0000.0%-1.33%
0
Exited
0(-100.0%)$3,1570.0%-40.58%
0
Exited
0(-100.0%)$17,1240.0%-1.33%
0

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used